Date: February 17-19, 2012
Date: January 10, 2012
NeoGenomics' medical staff ensure that your results matter.
FDA-Approved ALK FISH in NSCLC
Tech-Only Microdissection for Solid Tumor Molecular Tests
BRAF V600E/K/D in Melanoma
HER2 Gastric & Other Cancers
Myeloma Prognostic Risk Signature (MyPRS™) Gene Expression Profile
MelanoSITE, Melanoma FISH
MDS FISH Panel
CLL FISH Panel
EGFR Mutation Analysis
HER2 FISH Breast Panel
Bladder Cancer FISH Panel
Circulating Tumor Cells - Breast, Prostate, Colorectal